PAPER Kim TW, Cho HM, Choi SY, Suguira Y, Hayasaka T, Setou M, Koh HC, Hwang EM, Park JY, Kang SJ, Kim HS, Kim H, Sun W
SEARCH RESULTS
330890 RESULTS
PAPER Alani B, Salehi R, Sadeghi P, Zare M, Khodagholi F, Arefian E, Hakemi MG, Digaleh H
Silencing of Hsp90 chaperone expression protects against 6-hydroxydopamine toxicity in PC12 cells.
J Mol Neurosci. 2014 Mar;52(3):392-402. PubMed: 24234033PAPER Flight MH
Neurodegenerative disease: Tau immunotherapy targets transcellular propagation.
Nat Rev Drug Discov. 2013 Dec;12(12):904. Epub 2013 Nov 15 PubMed: 24232374PAPER Guo X, Disatnik MH, Monbureau M, Shamloo M, Mochly-Rosen D, Qi X
Inhibition of mitochondrial fragmentation diminishes Huntington's disease-associated neurodegeneration.
J Clin Invest. 2013 Dec 2;123(12):5371-88. Epub 2013 Nov 15 PubMed: 24231356PAPER Ulbrich L, Cozzolino M, Marini ES, Amori I, De Jaco A, Carrì MT, Augusti-Tocco G
Cystatin B and SOD1: protein–protein interaction and possible relation to neurodegeneration.
Cell Mol Neurobiol. 2014 Mar;34(2):205-13. PubMed: 24234043PAPER Dupuis JP, Feyder M, Miguelez C, Garcia L, Morin S, Choquet D, Hosy E, Bezard E, Fisone G, Bioulac BH, Baufreton J
Dopamine-dependent long-term depression at subthalamo-nigral synapses is lost in experimental parkinsonism.
J Neurosci. 2013 Sep 4;33(36):14331-41. PubMed: 24005286PAPER Kim C, Yun N, Lee YM, Jeong JY, Baek JY, Song HY, Ju C, Youdim MB, Jin BK, Kim WK, Oh YJ
Gel-based protease proteomics for identifying the novel calpain substrates in dopaminergic neuronal cell.
J Biol Chem. 2013 Dec 20;288(51):36717-32. Epub 2013 Nov 14 PubMed: 24235151PAPER Goris A, van Setten J, Diekstra F, Ripke S, Patsopoulos NA, Sawcer SJ, International Multiple Sclerosis Genetics Consortium, van Es M, Australia and New Zealand MS Genetics Consortium, Andersen PM, Melki J, Meininger V, Hardiman O, Landers JE, Brown RH Jr, Shatunov A, Leigh N, Al-Chalabi A, Shaw CE, Traynor BJ, Chiò A, Restagno G, Mora G, Ophoff RA, Oksenberg JR, Van Damme P, Compston A, Robberecht W, Dubois B, van den Berg LH, De Jager PL, Veldink JH, de Bakker PI
No evidence for shared genetic basis of common variants in multiple sclerosis and amyotrophic lateral sclerosis.
Hum Mol Genet. 2014 Apr 1;23(7):1916-22. Epub 2013 Nov 13 PubMed: 24234648PAPER Stoveken BJ
Tau pathology as a cause and consequence of the UPR.
J Neurosci. 2013 Sep 4;33(36):14285-7. PubMed: 24005281PAPER Rosén C, Rosén H, Andreasson U, Bremell D, Bremler R, Hagberg L, Rosengren L, Blennow K, Zetterberg H
Cerebrospinal fluid biomarkers in cardiac arrest survivors.
Resuscitation. 2014 Feb;85(2):227-32. Epub 2013 Nov 11 PubMed: 24231570PAPER Wang X, Yu S, Hu JP, Wang CY, Wang Y, Liu HX, Liu YL
Streptozotocin-induced diabetes increases amyloid plaque deposition in AD transgenic mice through modulating AGEs/RAGE/NF-κB pathway.
Int J Neurosci. 2014 Aug;124(8):601-8. Epub 2013 Dec 12 PubMed: 24228859PAPER Tesseur I, De Strooper B
When the dust settles: what did we learn from the bexarotene discussion?
Alzheimers Res Ther. 2013;5(6):54. Epub 2013 Nov 7 PubMed: 24229456PAPER Lautenschlager NT
Physical activity in Alzheimer's disease: research in its infancy or why we need more randomized controlled trials.
Int Psychogeriatr. 2014 Jan;26(1):7. Epub 2013 Nov 12 PubMed: 24229469PAPER Tang SS, Ji MJ, Chen L, Hu M, Long Y, Li YQ, Miao MX, Li JC, Li N, Ji H, Chen XJ, Hong H
Protective effect of pranlukast on Aβ₁₋₄₂-induced cognitive deficits associated with downregulation of cysteinyl leukotriene receptor 1.
Int J Neuropsychopharmacol. 2014 Apr;17(4):581-92. Epub 2013 Nov 11 PubMed: 24229499PAPER Dao AT, Zagaar MA, Salim S, Eriksen JL, Alkadhi KA
Regular exercise prevents non-cognitive disturbances in a rat model of Alzheimer's disease.
Int J Neuropsychopharmacol. 2014 Apr;17(4):593-602. Epub 2013 Nov 14 PubMed: 24229510Current Filters
No filters selected